Rituximab Shows Promise for Clinical Problems Tied to Antiphospholipid Antibodies
Hospital for Special SurgeryRituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, according to a new study by researchers at Hospital for Special Surgery.